Advanced Genomic Technology, LLC (AGT) is a biotechnology company based in Louisville, Kentucky, founded in December 2005. AGT’s mission is to develop and market a non-invasive, blood-based test for diagnosis and prognosis of: Alzheimer’s disease (AD) victims and at-risk groups, including individuals with mild cognitive impairment (MCI) and elderly > 65 years of age;

Quest Diagnostics Investments LLC, a subsidiary of Quest Diagnostics, Inc., is an American company specializing in medical laboratories.

Van Andel Institute provides biomedical research and education services. Its services include antibody production, spectral karyotyping, immunostaining and mouse modeling, animal imaging, computational biology, flow cytometry, germline modification and cytogenetics, mass spectrometry and proteomics, microarray technology, sequencing, vivarium, xenotransplantation and michigan animal consortium, as well as analytical, cellular and molecular microscopy services. The company was founded by Jay van Andel and Betty Van Andel in 1996 and is headquartered in Grand Rapids, MI.

University Health Network (UHN) is a healthcare and medical research organization in Toronto, Ontario, Canada. It is the largest such research organization in Canada and North America, ranking first in Canada for total research funding. It was named Canada's top research hospital by Research Infosource in 2015, 2016 and 2017. It was created in 1986 by the Government of Ontario through the merger of four major hospitals: Toronto General Hospital, Toronto Western Hospital, with the Princess Margaret Cancer Centre, and the Toronto Rehabilitation Institute merged in with The Toronto Hospital in 1999 and the name changed to the University Health Network. All four hospitals are affiliated with the Faculty of Medicine at the University of Toronto and serve as teaching hospitals for resident physicians, nurses, and other healthcare professions. UHN also operates The Michener Institute, an applied health sciences college that opened in 1958.

Firefly BioWorks, Inc. (Cambridge, MA) is introducing an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed biological assays on standard laboratory instrumentation. The company's core technology, Optical Liquid Stamping, was developed in the Chemical Engineering Department at MIT (News - Alert) by Firefly co-founders. The method allows rapid and scalable synthesis of encoded, multi-functional particles for the quantification of biological function. The company's long-term vision is to provide research and clinical scientists with reliable and affordable solutions for the comprehensive monitoring of biological systems.

Shenzhen Qiankang Pharmaceutical Technology Co., Ltd., established on 2015-02-28, Business scope includes general business items:biological reagent,biochemical drug,Chemical raw materials and their preparations,Antibiotic raw materials and their reagents,Research and development of biological and chemical intermediates;Invest in business(Specific projects will be reported separately);Domestic Trade(Does not contain franchise,monopoly,Specially Controlled Commodities);Operating import and export business(No restricted items);Food Safety Testing.,The licensing program is:biological reagent,biochemical drug,Chemical raw materials and their preparations,Production and sales of antibiotic raw materials and their reagents

Mirxes is a biotechnology company that discovers, develops, and delivers accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases. The company's mission is to make diagnostic solutions for the early detection of diseases accessible on a global scale. It develops and commercializes accurate and non-invasive blood-based miRNA test kit products for the early detection of cancer and other diseases.

Part of MOH Holdings Pte Ltd., Singapore Health Services Pte Ltd. is a Singaporean company located in Singapore. The firm provides medical services. Ivy Ng is the CEO, in this role since 2012.

Eisai R&D Management Co., Ltd., a subsidiary of Eisai Co., Ltd., is a company headquartered in Bunkyo, Japan. The firm engages in research and development of pharmaceuticals.

Academisch Ziekenhuis Maastricht operates as medical research centre. The company is headquartered in Maastricht, the Netherlands.

Zhuji Ruijian Biotechnology Co., Ltd., established on 2018-08-21, Business scope includes biotechnology,Technology research and development in the field of medical devices,Technical Services,technical consulting,technology transfer;Conference and Exhibition Services,Business Consulting(In addition to commodity intermediary),Business Management Consulting,marketing planning,Corporate Image Planning,Health Management Consulting Services(Does not include medical treatment),the first sort,Sales of Class II Medical Devices:Experimental instruments and accessories sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, established on 2006-06-27, Business scope includes

The Child Jesus is the largest Pediatric Clinic and Pediatric Research Center in Europe , linked to major international centers in the field. Nearly 2,600 people work in it, including physicians, researchers, nurses, hospital technicians and clerks . Also the number of patients treated is very large, for a total of over 1 million and 550,000 performances each year to children and children around the world . The size of a city inhabited by children who are cared for, followed and assisted, which are at the center of an affordable, comprehensive and quality healthcare offering.

John Wayne Cancer Institute is a private company headquartered in Santa Monica, CA, that operates cancer research institute.\nThe company says this about itself: Since 1981, the family of John Wayne has been committed to pioneering cancer research in memory of their father, who died of cancer. The courageous and dedicated researchers at the John Wayne Cancer Institute have made groundbreaking discoveries that have changed the way cancer is detected, diagnosed and treated around the world. Today the tradition of excellence continues as the Institute spearheads new research advances, while training the next generation of leaders in the fight against cancer through its renowned Surgical Oncology Fellowship Program. The Institute provides immediate hope to cancer patients everywhere.

Hadasit is the technology transfer company of Hadassah Medical Center in Jerusalem. They transform the cutting-edge research coming out of Hadassah into marketable medical technologies. They turn ground-breaking ideas into viable products and services that can change the world and better humanity. For more than a century, Hadassah has set the standard of excellence for medical care and research in Israel. Their doctors and scientists are on the frontlines, uniquely positioned to pinpoint ever-evolving medical needs. Their experience and ingenuity has yielded new ideas with huge potential in all areas of medicine, including therapeutics, diagnostic medical devices, and digital health. More than half of all hospital research in Israel is conducted at Hadassah. Hadasit is Hadassah’s vehicle for commercialization of the intellectual property and R&D capabilities developed there. Hadasit holds exclusive rights to every innovation and invention emerging from Hadassah and they are dedicated to bringing these life-saving technologies to the general public.